This finding is in line with the previous study showing that genistein, a promising pharmaceutical drug for CF patients, activates CFTR via the induction of PI3K/Akt‐dependent pathway in duodenal epithelial cells.37, 38. This evidence concerns the gene CFTR and cystic fibrosis.